4.7 Letter

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4(+)Foxp3(+) T cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Is FOXP3 a bona fide marker for human regulatory T cells?

Maria-Grazia Roncarolo et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2008)

Article Medicine, General & Internal

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

Meletios Dimopoulos et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Oncology

International uniform response criteria for multiple myeloma

B. G. M. Durie et al.

LEUKEMIA (2006)